1
|
Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment. Br J Nutr 2023; 129:406-415. [PMID: 35152926 PMCID: PMC9876810 DOI: 10.1017/s0007114522000435] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Malnutrition and sarcopenia are prevalent in patients with head and neck squamous cell carcinoma (HNSCC). Pre-treatment sarcopenia and adverse oncological outcomes in this population are well described. The impact of myosteatosis and post-treatment sarcopenia is less well known. Patients with HNSCC (n = 125) undergoing chemoradiotherapy, radiotherapy alone and/or surgery were assessed for sarcopenia and myosteatosis, using cross-sectional computed tomography (CT) imaging at the third lumbar (L3) vertebra, at baseline and 3 months post-treatment. Outcomes were overall survival (OS) at 12 months and 5 years post-treatment. One hundred and one participants had a CT scan evaluable at one or two time points, of which sixty-seven (66 %) participants were sarcopenic on at least one time point. Reduced muscle attenuation affected 93 % (n = 92) pre-treatment compared with 97 % (n = 90) post-treatment. Five-year OS favoured those without post-treatment sarcopenia (hazard ratio, HR 0·37, 95 % CI 0·16, 0·88, P = 0·06) and those without both post-treatment myosteatosis and sarcopenia (HR 0·33, 95 % CI 0·13, 0·83, P = 0·06). Overall, rates of myosteatosis were high at both pre- and post-treatment time points. Post-treatment sarcopenia was associated with worse 5-year OS, as was post-treatment sarcopenia in those who had myosteatosis. Post-treatment sarcopenia should be evaluated as an independent risk factor for decreased long-term survival post-treatment containing radiotherapy (RT) for HNSCC.
Collapse
|
2
|
Validation of a simple diet self-assessment tool (SDSAT) in head and neck cancer patients undergoing radiotherapy. Eur J Oncol Nurs 2019; 44:101702. [PMID: 31816506 DOI: 10.1016/j.ejon.2019.101702] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Revised: 11/08/2019] [Accepted: 11/26/2019] [Indexed: 11/24/2022]
Abstract
PURPOSE The simple diet self-assessment tool (SDSAT) is a simple instrument for estimating the cancer patients' dietary intake. This study aimed to evaluate its reliability and validity among head and neck (HNC) cancer patients undergoing radiotherapy (RT). METHODS Two studies were conducted at the department of radiation oncology of a University-affiliated hospital, where HNC patients were assessed at baseline, mid-treatment and post-treatment of RT. In the first study, 25 patients (a total of 60 cases) were recruited by convenience sample method to estimate the interrater reliability of SDSAT. Then, 304 patients (a total of 912 cases) were involved in a prospective, longitudinal observational study. The criterion validity was confirmed by the agreement rate between SDSAT and 24-h dietary recall (24HR). The predictive validity was established by exploring the impact of the score of SDSAT on weight loss among HNC patients during RT. RESULTS The estimation of interrater reliability of SDSAT showed that weighted kappa was 0.82 (95%CI = 0.74-0.90, p < 0.001), suggesting a high level of agreement between two raters. The overall agreement rate between SDSAT and 24HR was 62.9% (574/912) and weighted kappa was 0.66 (95%CI = 0.63-0.70, p < 0.001), which indicated good criterion validity. Generalized estimating equation (GEE) showed that the score of SDSAT had a significant impact on weight loss (β = 1.40, 95%CI = 1.21-1.59, p < 0.001), which demonstrated good predictive validity. CONCLUSIONS The SDSAT demonstrated favorable reliability and validity. It is appropriate for estimation of dietary intake among HNC patients.
Collapse
|
3
|
Brown T, Banks M, Hughes BG, Lin C, Kenny LM, Bauer JD. Impact of early prophylactic feeding on long term tube dependency outcomes in patients with head and neck cancer. Oral Oncol 2017; 72:17-25. [DOI: 10.1016/j.oraloncology.2017.06.025] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2017] [Accepted: 06/24/2017] [Indexed: 12/28/2022]
|
4
|
Brown T, Banks M, Hughes BGM, Lin C, Kenny L, Bauer J. Tube feeding during treatment for head and neck cancer - Adherence and patient reported barriers. Oral Oncol 2017; 72:140-149. [PMID: 28797450 DOI: 10.1016/j.oraloncology.2017.07.017] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Revised: 07/14/2017] [Accepted: 07/16/2017] [Indexed: 11/24/2022]
Abstract
OBJECTIVES The main aim was to investigate the incidence of patient adherence to nutritional tube feeding recommendations in patients with head and neck cancer and to determine patient barriers to meeting tube feeding prescription. MATERIALS AND METHODS This was an observational study from a randomised controlled trial in patients with head and neck cancer deemed at high nutritional risk with prophylactic gastrostomy (n=125). Patients were randomised to receive early tube feeding prior to treatment (intervention group) or standard care. All patients in the intervention and standard care groups then commenced clinical tube feeding as required during treatment. Patients maintained a daily record of gastrostomy intake, main nutrition impact symptom necessitating gastrostomy use, and reasons for not meeting nutrition prescription. Adherence was defined as meeting ≥75% of total prescribed intake. RESULTS Patients were predominantly male (89%), median age 60, with oropharyngeal tumours (78%), stage IV disease (87%) treated with chemoradiotherapy (87%). Primary reasons for gastrostomy use were poor appetite/dysgeusia (week 2-3) and odynophagia/mucositis (week 4-7). Early tube feeding adherence was 51%. Clinical tube feeding adherence was significantly higher in the intervention group (58% vs 38%, p=0.037). Key barriers to both phases of tube feeding were; nausea, early satiety and treatment factors (related to hospital healthcare processes). CONCLUSIONS Early tube feeding can improve patient adherence to clinically indicated tube feeding during treatment. Low adherence overall is a likely explanation for clinically significant weight loss despite intensive nutrition interventions. Optimising symptom management and strategies to overcome other barriers are key to improving adherence. CLINICAL TRIAL REGISTRATION This trial has been registered in the Australian New Zealand Clinical Trials registry as ACTRN12612000579897.
Collapse
Affiliation(s)
- Teresa Brown
- Centre for Dietetics Research (C-DIET-R), School of Human Movement Studies, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia; Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD 4029, Australia.
| | - Merrilyn Banks
- Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD 4029, Australia.
| | - Brett G M Hughes
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD 4029, Australia; School of Medicine, The University of Queensland, St Lucia, Brisbane, QLD 4029, Australia.
| | - Charles Lin
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD 4029, Australia; School of Medicine, The University of Queensland, St Lucia, Brisbane, QLD 4029, Australia.
| | - Lizbeth Kenny
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Brisbane, QLD 4029, Australia; School of Medicine, The University of Queensland, St Lucia, Brisbane, QLD 4029, Australia.
| | - Judith Bauer
- Centre for Dietetics Research (C-DIET-R), School of Human Movement Studies, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
| |
Collapse
|
5
|
Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer. Br J Cancer 2017; 117:15-24. [PMID: 28535154 PMCID: PMC5520203 DOI: 10.1038/bjc.2017.138] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Revised: 04/21/2017] [Accepted: 04/24/2017] [Indexed: 02/08/2023] Open
Abstract
Background: Weight loss remains significant in patients with head and neck cancer, despite prophylactic gastrostomy and intensive dietary counseling. The aim of this study was to improve outcomes utilising an early nutrition intervention. Methods: Patients with head and neck cancer at a tertiary hospital in Australia referred for prophylactic gastrostomy prior to curative intent treatment were eligible for this single centre randomised controlled trial. Exclusions included severe malnutrition or dysphagia. Patients were assigned following computer-generated randomisation sequence with allocation concealment to either intervention or standard care. The intervention group commenced supplementary tube feeding immediately following tube placement. Primary outcome measure was percentage weight loss at three months post treatment. Results: Recruitment completed June 2015 with 70 patients randomised to standard care (66 complete cases) and 61 to intervention (56 complete cases). Following intention-to-treat analysis, linear regression found no effect of the intervention on weight loss (10.9±6.6% standard care vs 10.8±5.6% intervention, P=0.930) and this remained non-significant on multivariable analysis (P=0.624). No other differences were found for quality of life or clinical outcomes. No serious adverse events were reported. Conclusions: The early intervention did not improve outcomes, but poor adherence to nutrition recommendations impacted on potential outcomes.
Collapse
|
6
|
Brown TE, Banks MD, Hughes BGM, Lin CY, Kenny LM, Bauer JD. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches. J Acad Nutr Diet 2016; 118:627-636. [PMID: 27986517 DOI: 10.1016/j.jand.2016.10.013] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Accepted: 10/13/2016] [Indexed: 12/18/2022]
Abstract
BACKGROUND The optimal method of tube feeding for patients with head and neck cancer remains unclear. A validated protocol is available that identifies high-nutritional-risk patients who would benefit from prophylactic gastrostomy tube placement. Adherence to this protocol is ultimately determined by clinical team discretion or patient decision. OBJECTIVE The study aim was to compare outcomes after adherence and nonadherence to this validated protocol, thus comparing a prophylactic and reactive approach to nutrition support in this patient population. DESIGN We conducted a prospective comparative cohort study. Patients were observed during routine clinical practice over 2 years. PARTICIPANTS/SETTING Patients with head and neck cancer having curative-intent treatment between August 2012 and July 2014 at a tertiary hospital in Queensland, Australia, were included if assessed as high nutrition risk according to the validated protocol (n=130). Patients were grouped according to protocol adherence as to whether they received prophylactic gastrostomy (PEG) per protocol recommendation (prophylactic PEG group, n=69) or not (no PEG group, n=61). MAIN OUTCOME MEASURES Primary outcome was percentage weight change during treatment. Secondary outcomes were feeding tube use and hospital admissions. STATISTICAL ANALYSIS PERFORMED Fisher's exact, χ2, and two sample t tests were performed to determine differences between the groups. Linear and logistic regression were used to examine weight loss and unplanned admissions, respectively. RESULTS Patients were 88% male, median age was 59 years, with predominantly stage IV oropharyngeal cancer receiving definitive chemoradiotherapy. Statistically significantly less weight loss in the prophylactic PEG group (7.0% vs 9.0%; P=0.048) and more unplanned admissions in the no PEG group (82% vs 75%; P=0.029). In the no PEG group, 26 patients (43%) required a feeding tube or had ≥10% weight loss. CONCLUSIONS Prophylactic gastrostomy improved nutrition outcomes and reduced unplanned hospital admissions. Additional investigation of characteristics of patients with minimal weight loss or feeding tube use could help refine and improve the protocol.
Collapse
|
7
|
Gastrostomy in head and neck cancer: current literature, controversies and research. Curr Opin Otolaryngol Head Neck Surg 2015; 23:162-70. [PMID: 25692626 DOI: 10.1097/moo.0000000000000135] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
PURPOSE OF REVIEW This article explores the literature on the role of gastrostomy tube feeding use in the management of head and neck cancer, with special attention to its indications, timing of insertion, advantages, complications and quality of life issues. RECENT FINDINGS The current guidelines in place across different countries and two ongoing randomized controlled trials are discussed in detail, and placed in the context of current evidence. SUMMARY There remains a lack of consensus about when and which enteral feeding routes (gastrostomy or nasogastric tube) should be used and controversy about the long-term effects on swallowing function as well as quality of life for patients. Local guidelines should be used or generated to guide practice or patients enrolled into existing trials until higher level evidence is generated.
Collapse
|
8
|
Kouhen F, Afif M, Benhmidou N, El Majjaoui S, Elkacemi H, Kebdani T, Benjaafar N. [What nutritional management in patients with head and neck cancers undergoing radiotherapy? An overview]. Bull Cancer 2015; 102:874-9. [PMID: 26384695 DOI: 10.1016/j.bulcan.2015.07.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2015] [Revised: 07/04/2015] [Accepted: 07/22/2015] [Indexed: 11/24/2022]
Abstract
Radiotherapy is an effective treatment for head and neck cancers but patients often experience side effects, which lead to malnutrition. Morbidity related to weight loss during treatment may include dehydration, hospitalization, compromised treatment efficacy, and reduced quality of life and may impact survival hence the importance of early nutritional management prior to radiotherapy. Multiple interventions have been implemented to help ameliorate the impact of treatment on weight loss and nutritional status, including the use of percutaneous endoscopic gastrostomy tubes. The goal of this overview is to search the predictive factors of malnutrition and an overview of the different types of nutritional interventions and their impact on the local control of the disease, mortality and quality of life of patients treated with radiotherapy or concomitant chemoradiotherapy.
Collapse
Affiliation(s)
- Fadila Kouhen
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc.
| | - Mohammed Afif
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc
| | - Naoual Benhmidou
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc
| | - Sanaa El Majjaoui
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc
| | - Hanan Elkacemi
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc
| | - Tayeb Kebdani
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc
| | - Noureddine Benjaafar
- Université Mohammed 5 Souissi, Institut national d'oncologie, service de radiothérapie, Rabat, Maroc
| |
Collapse
|
9
|
Leistra E, Eerenstein SEJ, van Aken LH, Jansen F, de van der Schueren MAE, Twisk JWR, Visser M, Langius JAE. Effect of Early Individualized Dietary Counseling on Weight Loss, Complications, and Length of Hospital Stay in Patients With Head and Neck Cancer: A Comparative Study. Nutr Cancer 2015; 67:1093-103. [PMID: 26317372 DOI: 10.1080/01635581.2015.1073755] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Patients with head and neck cancer (HNC) are at risk for undernutrition. Dietary counseling during treatment has positive effects on nutritional status and quality of life, however, the effects of dietary counseling started before initiation of treatment are currently unknown. Therefore we assessed the effect of early individualized dietary counseling (DC) on weight loss, major complications, and length of hospital stay (LOS) in patients with HNC. Ninety-five newly diagnosed HNC patients with (risk of) undernutrition receiving DC were compared to 95 matched HNC patients receiving usual nutritional care (UC). Difference in weight change over time was analyzed by generalized estimating equations (GEE). Differences in complications and LOS were studied by Pearson chi-squared and student's t-tests. Weight change between diagnosis and end of treatment was -6.0 ± 6.9% (DC) and -5.4 ± 5.7% (UC; GEE: -0.4kg, 95% confidence interval: -1.2 to 0.5; P = 0.44). Less DC patients experienced overall postoperative complications (44%/70%, P = 0.04). No effect on major postoperative or (chemo)radiotherapy complications or LOS was found. This study showed a lower prevalence of overall postoperative complications in HNC patients receiving DC but could not demonstrate an effect on weight loss, other complications, and LOS.
Collapse
Affiliation(s)
- Eva Leistra
- a Department of Nutrition and Dietetics, Internal Medicine , VU University Medical Center , Amsterdam , The Netherlands.,b Department of Nutrition and Dietetics, School of Sports and Nutrition , Amsterdam University of Applied Sciences , Amsterdam , The Netherlands
| | - Simone E J Eerenstein
- c Department of Otolaryngology/Head and Neck Surgery , VU University Medical Center , Amsterdam , The Netherlands
| | - Loes H van Aken
- a Department of Nutrition and Dietetics, Internal Medicine , VU University Medical Center , Amsterdam , The Netherlands
| | - Femke Jansen
- c Department of Otolaryngology/Head and Neck Surgery , VU University Medical Center , Amsterdam , The Netherlands
| | - Marian A E de van der Schueren
- a Department of Nutrition and Dietetics, Internal Medicine , VU University Medical Center , Amsterdam , The Netherlands.,d Department of Nutrition, Sports, and Health , HAN University of Applied Sciences , Nijmegen , The Netherlands
| | - Jos W R Twisk
- e Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research , VU University Medical Center , Amsterdam , The Netherlands
| | - Marjolein Visser
- e Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research , VU University Medical Center , Amsterdam , The Netherlands.,f Department of Health Sciences, Faculty of Earth and Life Sciences , VU University , Amsterdam , The Netherlands
| | - Jacqueline A E Langius
- a Department of Nutrition and Dietetics, Internal Medicine , VU University Medical Center , Amsterdam , The Netherlands.,g Academy of Health , The Hague University of Applied Sciences , The Hague , The Netherlands
| |
Collapse
|
10
|
Brown T, Banks M, Hughes BGM, Lin C, Kenny LM, Bauer JD. New radiotherapy techniques do not reduce the need for nutrition intervention in patients with head and neck cancer. Eur J Clin Nutr 2015; 69:1119-24. [PMID: 26306565 DOI: 10.1038/ejcn.2015.141] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2015] [Revised: 07/15/2015] [Accepted: 07/21/2015] [Indexed: 11/09/2022]
Abstract
BACKGROUND/OBJECTIVES Since 2007, our institution has used validated guidelines for the insertion of proactive gastrostomy feeding tubes in patients with head and neck cancer. Helical intensity-modulated radiotherapy (H-IMRT) delivered by Tomotherapy, is an advanced radiotherapy technique introduced at our centre in 2010. This form of therapy reduces long-term treatment-related toxicity to normal tissues. The aim of this study is to compare weight change and need for tube feeding following H-IMRT (n=53) with patients that would have previously been treated with three-dimensional conformal radiotherapy (n=134). SUBJECTS/METHODS Patients with head and neck cancer assessed as high nutritional risk with recommendation for proactive gastrostomy were identified from cohorts from 2007 to 2008 and 2010 to 2011. Retrospective data were collected on clinical factors, weight change from baseline to completion of treatment, incidence of severe weight loss (⩾ 10%) and tube feeding. Statistical analyses to compare outcomes between the two treatments included χ(2)-test, Fisher's exact and two-sample Wilcoxon tests (P<0.05). RESULTS The H-IMRT cohort had higher proportions of patients with definitive chemoradiotherapy (P=0.032) and more advanced N stage (P<0.001). Nutrition outcomes were not significantly different between H-IMRT and conformal radiotherapy, respectively: need for proactive gastrostomy (n=49, 92% versus n=115, 86%, P=0.213), median percentage weight change (-7.2% versus -7.3%, P=0.573) and severe weight loss incidence (28% versus 27%, P=0.843). CONCLUSIONS Both groups had median weight loss >5% and high incidences of tube feeding and severe weight loss. Nutrition intervention remains critical in this patient population, despite advances in radiotherapy techniques, and no changes to current management are recommended.
Collapse
Affiliation(s)
- T Brown
- Centre for Dietetics Research (C-DIET-R), School of Human Movement and Nutrition Sciences, University of Queensland, St Lucia, Queensland, Australia.,Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
| | - M Banks
- Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
| | - B G M Hughes
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.,School of Medicine, University of Queensland, St Lucia, Queensland, Australia
| | - C Lin
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
| | - L M Kenny
- Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
| | - J D Bauer
- Centre for Dietetics Research (C-DIET-R), School of Human Movement and Nutrition Sciences, University of Queensland, St Lucia, Queensland, Australia
| |
Collapse
|